Jointown Pharmaceutical Group Co., Ltd (SHA: 600998)
China
· Delayed Price · Currency is CNY 5.39
-0.59 (-9.87%)
Oct 9, 2024, 9:30 AM CST
Jointown Pharmaceutical Group Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 2,039 | 2,174 | 2,085 | 2,448 | 3,075 | 1,727 | Upgrade
|
| Depreciation & Amortization | 738.27 | 732.95 | 736.28 | 656.81 | 514.33 | 497.06 | Upgrade
|
| Other Amortization | 106.55 | 83.51 | 46.26 | 46.74 | 42.29 | 39.67 | Upgrade
|
| Loss (Gain) From Sale of Assets | -5.65 | -6.92 | -48.23 | -6.72 | -258.03 | -7.22 | Upgrade
|
| Asset Writedown & Restructuring Costs | 1.69 | 2.99 | 2.56 | 2.35 | 0.69 | 6.39 | Upgrade
|
| Loss (Gain) From Sale of Investments | -18.36 | 37.4 | -308.25 | -1,456 | -1,231 | -134.35 | Upgrade
|
| Provision & Write-off of Bad Debts | 28.44 | 131.87 | 160.56 | 201.32 | 184.7 | 64.16 | Upgrade
|
| Other Operating Activities | 1,161 | 1,242 | 1,642 | 1,369 | 1,481 | 1,350 | Upgrade
|
| Change in Accounts Receivable | -2,453 | 1,331 | -4,446 | -2,971 | -4,159 | -2,427 | Upgrade
|
| Change in Inventory | -1,341 | -2,828 | -1,633 | -720.4 | -737.5 | -1,055 | Upgrade
|
| Change in Accounts Payable | 742.41 | 1,880 | 5,933 | 3,724 | 4,305 | 2,731 | Upgrade
|
| Change in Other Net Operating Assets | 107.16 | 104.4 | 94.36 | - | - | - | Upgrade
|
| Operating Cash Flow | 1,029 | 4,748 | 3,986 | 3,459 | 3,444 | 2,768 | Upgrade
|
| Operating Cash Flow Growth | -84.32% | 19.10% | 15.24% | 0.44% | 24.42% | 126.50% | Upgrade
|
| Capital Expenditures | -946.44 | -1,049 | -1,243 | -1,386 | -1,457 | -1,192 | Upgrade
|
| Sale of Property, Plant & Equipment | 165.28 | 163.42 | 160.85 | 171.49 | 298.62 | 17.68 | Upgrade
|
| Cash Acquisitions | 120.28 | -61.27 | -286.29 | -28.58 | 82.51 | 15.34 | Upgrade
|
| Divestitures | 55.2 | 34.57 | 126.75 | -22.72 | -79.56 | 45.18 | Upgrade
|
| Investment in Securities | -585.6 | -484.57 | 2,805 | -1,382 | -195.33 | -232.2 | Upgrade
|
| Other Investing Activities | 38.64 | 35.54 | -75.28 | 105.3 | 75.96 | 105.83 | Upgrade
|
| Investing Cash Flow | -1,153 | -1,361 | 1,488 | -2,543 | -1,275 | -1,240 | Upgrade
|
| Short-Term Debt Issued | - | 2,124 | 3,280 | 3,311 | 913.2 | 1,153 | Upgrade
|
| Long-Term Debt Issued | - | 17,772 | 19,748 | 18,467 | 22,392 | 23,932 | Upgrade
|
| Total Debt Issued | 21,574 | 19,896 | 23,028 | 21,777 | 23,306 | 25,085 | Upgrade
|
| Short-Term Debt Repaid | - | -4,251 | -1,582 | -1,004 | -1,521 | -89.31 | Upgrade
|
| Long-Term Debt Repaid | - | -18,122 | -23,295 | -20,258 | -22,905 | -26,524 | Upgrade
|
| Total Debt Repaid | -19,933 | -22,373 | -24,877 | -21,263 | -24,425 | -26,614 | Upgrade
|
| Net Debt Issued (Repaid) | 1,641 | -2,477 | -1,849 | 514.42 | -1,120 | -1,529 | Upgrade
|
| Issuance of Common Stock | - | 461.59 | 195.35 | 143.68 | - | - | Upgrade
|
| Repurchase of Common Stock | -93.06 | - | -425.76 | -0.11 | -300.01 | -600.01 | Upgrade
|
| Common Dividends Paid | -1,735 | -1,635 | -1,388 | -1,682 | -737.68 | -1,140 | Upgrade
|
| Other Financing Activities | 3,467 | 3,413 | -1,433 | -993.65 | 1,974 | 426.63 | Upgrade
|
| Financing Cash Flow | 1,280 | -2,237 | -4,901 | -2,017 | -183.54 | -2,842 | Upgrade
|
| Foreign Exchange Rate Adjustments | -3.07 | -1.01 | 9.6 | -3.5 | -3.48 | 0.71 | Upgrade
|
| Net Cash Flow | 1,153 | 1,149 | 582.99 | -1,105 | 1,982 | -1,314 | Upgrade
|
| Free Cash Flow | 82.26 | 3,699 | 2,743 | 2,073 | 1,987 | 1,576 | Upgrade
|
| Free Cash Flow Growth | -98.48% | 34.86% | 32.32% | 4.33% | 26.09% | - | Upgrade
|
| Free Cash Flow Margin | 0.06% | 2.46% | 1.95% | 1.69% | 1.79% | 1.58% | Upgrade
|
| Free Cash Flow Per Share | 0.02 | 0.73 | 0.52 | 0.40 | 0.37 | 0.28 | Upgrade
|
| Cash Income Tax Paid | 2,964 | 3,019 | 2,571 | 2,295 | 1,920 | 1,797 | Upgrade
|
| Levered Free Cash Flow | 421.89 | 1,466 | 2,962 | 2,729 | -802.28 | 2,164 | Upgrade
|
| Unlevered Free Cash Flow | 1,229 | 2,290 | 3,725 | 3,445 | -160.13 | 2,939 | Upgrade
|
| Change in Net Working Capital | 1,267 | 291.97 | -1,723 | -2,118 | 1,639 | -1,533 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.